Trending...
- Alcoa Announces Closure of Intalco Smelter and Prepares Site for Redevelopment
- Bounce House Rentals Near Me Provider for Pittsburgh PA And Surrounding Areas
- Congressman Mark Alford endorsed by Veterans for Trump on his 2024 re-election
Platform reduces friction across the eConsent, IRT, and eCOA user experience for sponsors, CROs, sites and patients.
PHILADELPHIA, Feb. 6, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, today unveiled a purpose-built software platform designed specifically to provide drug trial sponsors and sites a seamless way to manage complex, mission-critical, and time-sensitive moments on the patient journey. Click to tweet.
Drawing on more than a decade of expertise following the launch of its innovative IRT solution, and having supported more than 1,000 trials across 80 countries, Suvoda introduces a low-code/no-code platform to the eClinical market unifying its eConsent, IRT, and eCOA solutions. Designed to address real challenges facing clinical trials, the Suvoda Platform minimizes friction across the user experience, while reducing and simplifying integrations, and strengthening data governance, so studies can be implemented more efficiently and with less risk of downtime.
"Clinical trials are increasingly complex, expensive, and fraught with challenges that are affecting trial execution – mid-study changes, data silos, trial delays, and more," said Jagath Wanninayake, CEO of Suvoda. "To meet these challenges, our team organically built a platform upon which we are delivering the next generation of clinical trial applications designed to handle complexity with ease, and reduce overall risk throughout trials. Our goal is always for sponsors and site users to spend less time with technology and more time on what is most important to them…uncovering scientific breakthroughs and focusing on the patients we all ultimately serve."
The Suvoda Platform enables Suvoda's IRT, eConsent, and eCOA solutions to work seamlessly together and harmoniously with other applications, to be easily tailored to meet the needs of each protocol, and to be upgradable to benefit from continuous enhancements. The Suvoda Platform provides a number of benefits, including:
More on The PennZone
Enhanced user experience and reduced workload. The new platform enables single sign-on and provides a consistent interface across Suvoda's eConsent, IRT, and eCOA solutions, with smooth user workflows that allow clinicians to move seamlessly from one task to the next. This reduces workload and training so sites can focus more of their time on research and patients.
Rapid design and deployment of complex trials. The platform's low-code/no-code technology streamlines study start-up and mid-study changes, even for the most complex trials, while advanced design tools make customizations more practical and sponsor standards easier to implement. A harmonized deployment process across three solutions saves study teams time and effort.
Improved data workflow and reduced integrations. Suvoda's unified platform enables all patient and site data across eConsent, IRT, and eCOA to be centrally collected, managed, analyzed, and stored. This is expected to result in better data governance for sponsors, provide sites access to real-time information, and deliver a more robust eClinical ecosystem. In addition, customers benefit from three already-integrated solutions–eConsent, IRT and eCOA–while the platform's comprehensive API surface simplifies other necessary integrations with third-party solutions and sponsor systems.
Future-proofed eClinical programs. Users of the platform will always have the latest trial technology with Suvoda because upgrades can be made throughout the life of the trial without losing customizations. In addition, with release opt-in, customers can choose which updates to accept, giving them control of their internal validation, acceptance, and training processes. Finally, Suvoda makes implementing enterprise standards future-proof by allowing sponsors to upgrade while maintaining their proprietary processes and standards across all products built on the Suvoda Platform.
"Whether it's sponsors, CROs, site teams, or patients, users expect a seamless trial experience digitally and in-person, so we've designed the new platform to deliver that," said Andrew McVeigh, chief architect at Suvoda. "Suvoda offers a powerful trial management platform that feels like a consumer app because we've put the user at the center of our design. Our robust back-end and intuitive design puts greater control into our customers' hands and delivers the power to manage trials of any level of complexity."
More on The PennZone
Click here for more information on the Suvoda Platform.
About Suvoda
Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest, Romania, and Tokyo, Japan. The company consistently boasts a Net Promoter Score (NPS) of close to 70, far exceeding the technology industry average of 50, and has been selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries. To learn more, visit suvoda.com. Follow Suvoda on Twitter and LinkedIn.
For information contact:
Mara Conklin, (847) 340-6823
[email protected]
Kathy Zoeller, (312) 485-2422
[email protected]
Logo - https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg
SOURCE Suvoda LLC
PHILADELPHIA, Feb. 6, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, today unveiled a purpose-built software platform designed specifically to provide drug trial sponsors and sites a seamless way to manage complex, mission-critical, and time-sensitive moments on the patient journey. Click to tweet.
Drawing on more than a decade of expertise following the launch of its innovative IRT solution, and having supported more than 1,000 trials across 80 countries, Suvoda introduces a low-code/no-code platform to the eClinical market unifying its eConsent, IRT, and eCOA solutions. Designed to address real challenges facing clinical trials, the Suvoda Platform minimizes friction across the user experience, while reducing and simplifying integrations, and strengthening data governance, so studies can be implemented more efficiently and with less risk of downtime.
"Clinical trials are increasingly complex, expensive, and fraught with challenges that are affecting trial execution – mid-study changes, data silos, trial delays, and more," said Jagath Wanninayake, CEO of Suvoda. "To meet these challenges, our team organically built a platform upon which we are delivering the next generation of clinical trial applications designed to handle complexity with ease, and reduce overall risk throughout trials. Our goal is always for sponsors and site users to spend less time with technology and more time on what is most important to them…uncovering scientific breakthroughs and focusing on the patients we all ultimately serve."
The Suvoda Platform enables Suvoda's IRT, eConsent, and eCOA solutions to work seamlessly together and harmoniously with other applications, to be easily tailored to meet the needs of each protocol, and to be upgradable to benefit from continuous enhancements. The Suvoda Platform provides a number of benefits, including:
More on The PennZone
- Announcing the Dr. Monti Show on Integrative Health and the Intersection of Science, Health, and Personal Well-Being, Premiering March 24, 2023, at 7:30pm
- Dental Implants in Center Valley Helping Patients Achieve Fuller Smiles
- Wohler releases out-of-band configuration tools for Riedel 2110 SFP's
- Benjamin Ross Group, LLC Sells Manufacturing Company, Frederick County, VA
- Levinger Regens Announces New Initiative to Improve Hydrogen Carbon Intensity
Enhanced user experience and reduced workload. The new platform enables single sign-on and provides a consistent interface across Suvoda's eConsent, IRT, and eCOA solutions, with smooth user workflows that allow clinicians to move seamlessly from one task to the next. This reduces workload and training so sites can focus more of their time on research and patients.
Rapid design and deployment of complex trials. The platform's low-code/no-code technology streamlines study start-up and mid-study changes, even for the most complex trials, while advanced design tools make customizations more practical and sponsor standards easier to implement. A harmonized deployment process across three solutions saves study teams time and effort.
Improved data workflow and reduced integrations. Suvoda's unified platform enables all patient and site data across eConsent, IRT, and eCOA to be centrally collected, managed, analyzed, and stored. This is expected to result in better data governance for sponsors, provide sites access to real-time information, and deliver a more robust eClinical ecosystem. In addition, customers benefit from three already-integrated solutions–eConsent, IRT and eCOA–while the platform's comprehensive API surface simplifies other necessary integrations with third-party solutions and sponsor systems.
Future-proofed eClinical programs. Users of the platform will always have the latest trial technology with Suvoda because upgrades can be made throughout the life of the trial without losing customizations. In addition, with release opt-in, customers can choose which updates to accept, giving them control of their internal validation, acceptance, and training processes. Finally, Suvoda makes implementing enterprise standards future-proof by allowing sponsors to upgrade while maintaining their proprietary processes and standards across all products built on the Suvoda Platform.
"Whether it's sponsors, CROs, site teams, or patients, users expect a seamless trial experience digitally and in-person, so we've designed the new platform to deliver that," said Andrew McVeigh, chief architect at Suvoda. "Suvoda offers a powerful trial management platform that feels like a consumer app because we've put the user at the center of our design. Our robust back-end and intuitive design puts greater control into our customers' hands and delivers the power to manage trials of any level of complexity."
More on The PennZone
- Eve Wellness, a SF Breast Ultrasound Screening Clinic supports the recent FDA updates to the guidelines to inform women about breast density
- Strategic Solution Partners Expands Its Hospitality Consulting Team to make Executive-Level Advice Available to Hotel Operators
- Expert tip: Private Jet Engine Maintenance Program - Pros and Cons for Preowned Jet Buyers
- Gaming and entertainment company Spinrack Corporation, appoints Jesse Norton as Chief Marketing Officer
- Pizzawiki.com: The Ultimate Pizza Resource for Pizza Lovers Everywhere!
Click here for more information on the Suvoda Platform.
About Suvoda
Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest, Romania, and Tokyo, Japan. The company consistently boasts a Net Promoter Score (NPS) of close to 70, far exceeding the technology industry average of 50, and has been selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries. To learn more, visit suvoda.com. Follow Suvoda on Twitter and LinkedIn.
For information contact:
Mara Conklin, (847) 340-6823
[email protected]
Kathy Zoeller, (312) 485-2422
[email protected]
Logo - https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg
SOURCE Suvoda LLC
Filed Under: Business
0 Comments
Latest on The PennZone
- HGR Alcohol Detox Centers in San Diego Accepts Most Health Insurances
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fidelity National Information Services, Inc. (FIS) Investors
- ShopCHARLI.com Launches Online Store With a Hot New Spring Collection that Doesn't Miss
- ICYMI: Governor Shapiro Touts His Plans to Rebuild Pennsylvania's Workforce, Recruit More Teachers, Cops, & Nurses
- Bounce House Rentals Near Me Provider for Pittsburgh PA And Surrounding Areas
- Pennsylvania: Governor Josh Shapiro Highlights Commonsense Proposal to Recruit More Nurses, Invest in Healthier Communities
- Congressman Mark Alford endorsed by Veterans for Trump on his 2024 re-election
- February 2023 Financial Market Review
- Bicycle Sunshade Expands Product Line with Two New Colors
- The Past Reflects A Future - Daniel Imperato 2024 Is Back Again. Which Party?
- Performance Hydration Leader Ready® Joins Global Tennis Market
- INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Marathon Digital Holdings, Inc. (MARA) on Behalf of Investors
- Fridge Art Fair New York City May 2023
- Empowering SMEs: Innervation's Supply Chain Finance Solutions for Diverse Business Growth
- AdvisorVault Partners With Compliant Workspace to Help FINRA Firms Achieve 17a-4 Compliance on Microsoft 365
- Alcoa Announces Closure of Intalco Smelter and Prepares Site for Redevelopment
- Pennsylvania: Governor Josh Shapiro Highlights Commonsense Proposal to Recruit More Police Officers and Invest in Public Safety at Lackawanna College Police Academy
- Pennsylvania: Gov. Shapiro Highlights Plans to Rebuild Workforce, Recruit More Teachers into PA Classrooms During Visit to Philadelphia High School
- RE/MAX Classic Realtors Announces Top Honors for Their High Achieving Real Estate Teams
- Free Training From The Tax Lien Lady – Tax Lien Investing 3-Day Challenge!